With the promising preliminary data, IDH1/2 inhibition represents a highly specific therapy for this subset of cancers.183, 184 Metabolic reprogramming in cancer cells might also be targeted by epigenetic drugs such as DNMT and HDAC inhibitors. Here, IDH1 is linked to cancer.